HeiQ Medica, a division of materials innovation conglomerate HeiQ Group, has granted Laboratorios Combix exclusive rights to distribute its products to pharmacies in Spain, bringing HeiQ Medica medical supplies and other products to every corner of Spain.
HeiQ Medica and Laboratorios Combix have signed an agreement that gives Combix the exclusive right to distribute HeiQ Medica made-in-EU products to all pharmacies in Spain. Combix has a nationwide marketing and sales network, and with its sales forces of 50+ representatives and other resources, it will promote and distribute the full range of HeiQ Medica products to the 22’000 Spanish pharmacies. Products such as FFP2 masks, reusable masks, EU-made surgical type IIR masks and gowns will be HeiQ Medica and Combix co-branded and will be available exclusively at pharmacies throughout Spain.
Pedro Herranz, CEO of HeiQ Medica said: “Since the establishment of HeiQ Medica, we have been inspired by the innovative spirit of HeiQ and have been growing from strength to strength. Our latest collaboration agreement appointing Combix as the first company to exclusively distribute our 100% European made innovations in Spain is one such example and I am truly looking forward to working with them and making our quality products accessible for people in pharmacies across the country.”
Swiss Technology Award 2020 Winning HeiQ Viroblock
HeiQ Viroblock turns any fabric antiviral. It’s one of the first textile technology in the world to be proven effective against SARS-CoV-2 (COVID-19)*. HeiQ Viroblock consists of a combination of HeiQ’s patent-pending vesicle and silver technologies. The two mechanisms of attack result in minutes 100% destruction of viruses and bacteria that is unrivaled in the industry.
Juan Luis Fernandez Balaguer, CEO of Combix is happy to seize this opportunity as exclusive distributor, saying: “We share so many values and ethical ideals with HeiQ Medica and given the synergy between their high-quality PPE products and our sales competence I am confident that we will make a serious impact on improving the lives of Spanish people as we drive these excellent technologies to market.”
Visit the HeiQ Medica website and shop for more information.
* M.J. (2020) Report on “Viral Stability and Persistence of SARS-CoV-2 on Treated Material”. Doherty Institute for Infection and Immunity, Australia
Laboratorios Combix is a pharmaceutical company dedicated to the commercialization of generic and OTC drugs, medical devices, self-care health products, food supplements, cosmetics and personal protective equipment. The company was found in 2007 in Spain and it was acquired by the multinational Zydus Cadila. Currently, Laboratorios Combix has a portfolio of more than 200 generic drug lines (belonging to the main therapeutic areas), which have allowed them to reach a turnover of 20 million euros.